<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar1981</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Correction</dochead>
      <bibl>
         <title>
            <p>Correction: Fish oil: what the prescriber needs to know</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Cleland</snm>
               <mi>G</mi>
               <fnm>Leslie</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2" ca="yes">
               <snm>James</snm>
               <mi>J</mi>
               <fnm>Michael</fnm>
               <insr iid="I1"/>
               <email>mjames@mail.rah.s.gov.au</email>
            </au>
            <au id="A3">
               <snm>Proudman</snm>
               <mi>M</mi>
               <fnm>Susanna</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, Australia</p>
            </ins>
         </insg>
         <source>Arthritis Research &amp; Therapy</source>
         <issn>1478-6354</issn>
         <pubdate>2006</pubdate>
         <volume>8</volume>
         <issue>4</issue>
         <fpage>402</fpage>
         <url>http://arthritis-research.com/content/8/4/402</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/ar1981</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>1</day>
               <month>6</month>
               <year>2006</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2006</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p/>
         </st>
         <p>It has been brought to our attention that there were a number of typographical errors in one section of our recent article <abbrgrp><abbr bid="B1">1</abbr></abbrgrp> published in December 2005.</p>
         <p>All corrections apply to the section entitled, 'Biochemical rationale; Eicosanoids: cyclo-oxygenase pathway'.</p>
         <p>The second paragraph should read:</p>
         <p>The usual substrate for the COX isozymes is the n6 LC PUFA arachidonic acid (AA; C20:4n-6). Eicosapentaenoic acid (EPA; C20:5n-3), which is present in fish oil, differs from AA only by the presence of its n3 bond (Fig. 1).</p>
         <p>The last sentence of the third paragraph should read:</p>
         <p>Thus, the net effect of fish oil is to reduce the production of proinflammatory and pro-thrombotic eicosanoids (PGE<sub>2 </sub>and TXA<sub>2</sub>, respectively) but not the vascular patency factor prostacyclin (PGI<sub>2</sub>; Fig. 2).</p>
         <p>Finally, the first 20-Carbon fatty acid homologue pictured in Figure 1 (C20:3 n-9) is eicosatrienoic acid, rather than oleic acid.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Fish oil: what the prescriber needs to know</p>
            </title>
            <aug>
               <au>
                  <snm>Cleland</snm>
                  <fnm>LG</fnm>
               </au>
               <au>
                  <snm>James</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Proudman</snm>
                  <fnm>SM</fnm>
               </au>
            </aug>
            <source>Arthritis Research &amp; Therapy</source>
            <pubdate>2006</pubdate>
            <volume>8</volume>
            <fpage>202</fpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1186/ar1876</pubid>
                  <pubid idtype="pmpid" link="fulltext">16542466</pubid>
                  <pubid idtype="pmcid">1526555</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
